Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fortunato Morabito

Showing results (51-60 of 302) with videos related to

Pageof 31
Sort By:
Expert Opinion on Pharmacotherapy|February 10, 2015
Smoldering multiple myeloma: to treat or not to treatMassimo Gentile, Massimo Offidani, Ernesto Vigna, et al.
Molecular and Clinical Oncology|August 20, 2024
Trends in cervical cancer: A decade‑long analysis of incidence, survival and demographic disparities in a Northern Italian provinceLucia Mangone, Francesco Marinelli, Isabella Bisceglia, et al.
Cancers|July 2, 2021
Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic OpportunitiesCirino Botta, Francesco Mendicino, Enrica Antonia Martino, et al.
Cancer Management and Research|November 21, 2025
Advancing Prognostic Accuracy Beyond Classical N Staging in Colorectal Cancer: An Observational Cohort Study to Define a Lymph Node Ratio Based Risk ScoreLucia Mangone, Fortunato Morabito, Giovanni Tripepi, et al.
Biology|November 24, 2023
Incidence and Survival of Testicular Cancers in a Province in Northern Italy and Their Association with Second TumorsLucia Mangone, Francesco Marinelli, Isabella Bisceglia, et al.
Leukemia & Lymphoma|December 17, 2002
Prospective study of indolent non-follicular non-Hodgkin's lymphoma: validation of Gruppo Italiano per lo studio dei linfomi (GISL) prognostic criteria for watch and wait policyFortunato Morabito, Luca Baldini, Caterina Stelitano, et al.
Leukemia Research|June 17, 2008
Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemiaStefano Molica, Giovanna Digiesi, Francesca Mauro, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 26, 2017
Autologous Stem Cell Transplantation in Patients With Multiple Myeloma: An Activity-based Costing Analysis, Comparing a Total Inpatient Model Versus an Early Discharge ModelMassimo Martino, Giuseppe Console, Letteria Russo, et al.
Cancers|November 13, 2021
Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple MyelomaKatia Todoerti, Domenica Ronchetti, Noemi Puccio, et al.
British Journal of Haematology|February 13, 2003
Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patientsSara Galimberti, Fortunato Morabito, Francesca Guerrini, et al.
Pageof 31

Showing results (51-60 of 302) with videos related to

Sort By:
Pageof 31
Expert Opinion on Pharmacotherapy|February 10, 2015
Smoldering multiple myeloma: to treat or not to treatMassimo Gentile, Massimo Offidani, Ernesto Vigna, et al.
Molecular and Clinical Oncology|August 20, 2024
Trends in cervical cancer: A decade‑long analysis of incidence, survival and demographic disparities in a Northern Italian provinceLucia Mangone, Francesco Marinelli, Isabella Bisceglia, et al.
Cancers|July 2, 2021
Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic OpportunitiesCirino Botta, Francesco Mendicino, Enrica Antonia Martino, et al.
Cancer Management and Research|November 21, 2025
Advancing Prognostic Accuracy Beyond Classical N Staging in Colorectal Cancer: An Observational Cohort Study to Define a Lymph Node Ratio Based Risk ScoreLucia Mangone, Fortunato Morabito, Giovanni Tripepi, et al.
Biology|November 24, 2023
Incidence and Survival of Testicular Cancers in a Province in Northern Italy and Their Association with Second TumorsLucia Mangone, Francesco Marinelli, Isabella Bisceglia, et al.
Leukemia & Lymphoma|December 17, 2002
Prospective study of indolent non-follicular non-Hodgkin's lymphoma: validation of Gruppo Italiano per lo studio dei linfomi (GISL) prognostic criteria for watch and wait policyFortunato Morabito, Luca Baldini, Caterina Stelitano, et al.
Leukemia Research|June 17, 2008
Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemiaStefano Molica, Giovanna Digiesi, Francesca Mauro, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 26, 2017
Autologous Stem Cell Transplantation in Patients With Multiple Myeloma: An Activity-based Costing Analysis, Comparing a Total Inpatient Model Versus an Early Discharge ModelMassimo Martino, Giuseppe Console, Letteria Russo, et al.
Cancers|November 13, 2021
Dissecting the Biological Relevance and Clinical Impact of lncRNA MIAT in Multiple MyelomaKatia Todoerti, Domenica Ronchetti, Noemi Puccio, et al.
British Journal of Haematology|February 13, 2003
Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patientsSara Galimberti, Fortunato Morabito, Francesca Guerrini, et al.
Pageof 31